Dengue Cases in the Philippines Dropped in 2026. The Rainy Season Is Here.

Where the Numbers Stand in 2026

The 2024 dengue year was already alarming in isolation. The Philippines recorded 413,960 dengue cases across the full year of 2024, the second highest annual count on record after 2019, according to data analyzed in the PMC12543447 nationwide study. That surge was followed in early 2025 by a further acceleration, with 62,313 cases recorded in January and February 2025 alone, a 73 percent rise over the same period in 2024, and Quezon City declaring an outbreak after 10 deaths including eight minors. By May 10, 2025, the DOH had already logged over 110,000 cases and 437 deaths nationally, with most deaths among children aged five to nine. Full-year 2025 regional surveillance reached 102,562 confirmed cases and 412 deaths.

In 2026, the trajectory has shifted. The DOH recorded 50,727 dengue cases in the first five months of the year, a 56 percent decline from the same period in 2025. Health officials attributed the improvement to sustained community cleanup drives and the DOH's 4Ts vector control campaign, which focuses on emptying, shaking out, drying, and covering water containers to disrupt mosquito breeding cycles. The Asia-Pacific regional surveillance tracker recorded 4,094 dengue cases and 1 death in the Philippines as of June 14, 2026, with week 24 hospitalized cases reaching 490. The DOH has flagged that with the full rainy season now arriving, case counts are expected to climb. Forecasting models using NNAR methodology project an annual average of 444,678 cases from 2025 to 2027, meaning the 2026 downward trend in the first half of the year may not hold through the peak wet-season months.

Why Climate Change Is Rewiring the Dengue Calendar

Dengue transmission depends on a precise set of environmental conditions. The Aedes aegypti mosquito, the primary vector, breeds most efficiently in small bodies of still water at temperatures between approximately 25 and 35 degrees Celsius. As the Philippines experiences warming baseline temperatures and more unpredictable rainfall patterns, those conditions are being met across more of the calendar year, not just during the traditional wet season. DOH officials noted in early 2025 that mosquitoes were breeding and biting outside their usual active periods, driven by unseasonal rainfall from the shearline, Intertropical Convergence Zone, and easterlies generating ideal breeding conditions during months that were previously dry.

A spatio-temporal analysis published in 2025 and linking climate factors to dengue transmission across the Philippines found that reported dengue incidence varied unpredictably with elevation and population density, but that the underlying force of infection, meaning the actual rate at which people were exposed to the virus including asymptomatic cases, showed consistent patterns: transmission was highest in low-lying, densely populated urban areas and declined at higher elevations. As warming reduces the elevation threshold at which Aedes mosquitoes can survive and breed, dengue risk is expanding geographically into areas that historically saw low transmission.

The global picture reinforces the Philippine trend. From 1990 to 2019, estimated dengue incidence increased by 85.5 percent worldwide, and from 2021 the number of global cases has been reported to double each year, according to eClinicalMedicine 2024 and the European Centre for Disease Prevention and Control. The disease is now endemic in more than 100 countries, with all WHO regions affected. The Philippines, already among the highest-burden countries in the Western Pacific, sits near the centre of this expanding risk zone.

Who Is Most Affected, and Why Children Bear the Heaviest Burden

Dengue can affect anyone, but children, particularly those under 15, consistently account for the largest share of hospitalizations and deaths in Philippine outbreak data. Of the 412 deaths recorded in 2025, the majority were among children, mirroring the pattern seen in previous outbreak years. The biological vulnerability is partially immunological: children who have had dengue once are at higher risk of severe dengue hemorrhagic fever upon a second infection with a different serotype. As dengue transmission intensifies and geographic reach expands, more children are encountering their first and potentially second dengue infections earlier in life.

Urban density is a consistent amplifier of risk. The DOH's 2025 surveillance identified CALABARZON, the National Capital Region, and Central Luzon as consistently among the three highest-burden regions, together accounting for the majority of cases and the most severe outbreaks. These are also among the most densely populated and rapidly urbanizing areas of the country, environments where water storage practices, waste collection gaps, and high human-to-mosquito contact rates combine to create conditions where Aedes mosquitoes thrive.

Prevention, Vaccines, and What the DOH Is Recommending

Vector control remains the primary line of defense. The DOH's twin campaigns, "Taob, Taktak, Tuyo, Takip" and "Alas-kwatro kontra mosquito" focus on four simple household practices: emptying standing water, scrubbing containers to remove mosquito eggs, drying water storage surfaces, and covering stored water. These are evidence-based interventions that reduce Aedes breeding sites without requiring clinical infrastructure. The 4 PM campaign encourages a daily check of potential breeding sites, recognizing that Aedes mosquitoes are most active in the early morning and late afternoon hours.

On vaccination, the Philippine Medical Association urged President Marcos in early 2025 to prioritize the approval of an advanced dengue vaccine. The landscape of dengue vaccination has evolved considerably since the controversial Dengvaxia rollout of 2016 to 2017. The newer Qdenga vaccine, developed by Takeda, does not require prior dengue infection to be safely administered and has demonstrated efficacy against all four dengue serotypes in clinical trials. As of 2025, the DOH was reviewing expanded immunization options, though access and affordability for the general population remain open policy questions.

• Warning signs of severe dengue that require immediate hospital care include abdominal pain, persistent vomiting, bleeding from the nose or gums, blood in stool or urine, difficulty breathing, and sudden decrease in alertness
• Fever alone does not indicate severe dengue, but fever combined with any warning sign should prompt immediate medical consultation
• The critical phase of dengue typically occurs as fever breaks, between days 3 and 7 of illness, when plasma leakage and platelet drop are most dangerous
• Paracetamol is the only recommended fever management for suspected dengue; aspirin, ibuprofen, and naproxen must be avoided as they increase bleeding risk